EIT Digital Innovation Activity 'ki elements' Showcases its First Prototype: DELTA

EIT DigitalThe EIT Digital Innovation Activity 'ki elements' showcases its first prototype called DELTA in Nice at the Institut Claude Pompidou on Innovation Alzheimer Open Day.

In the beginning of 2017, EIT Digital launched ELEMENT, a new Innovation Activity to facilitate faster, earlier diagnosis and intervention for cognitive decline.

In June 2017, the Innovation Activity ELEMENT took a new step forward with the official launch of its start-up: ki elements.

CEO Jan Alexandersson (also Activity Lead) of ELEMENT explains: "We are very proud and happy to showcase our first prototype called Delta during the Innovation Alzheimer Day in collaboration with Association Innovation Alzheimer at the Institut Claude Pompidou in Nice. Our prototype is an iPad app for psychometric testing based on language as diagnosis support for professionals working in psychiatry, neuropsychology and speech pathology."

How the Delta app works:

  • Delta records and saves speech data and synchronises it with your HIS (Hospital Information System). This allows you to easily re-listen to patients and empowers your professional decisions.
  • Delta automatically transcribes answers from cognitive speech tests to keep your attention free for the most important thing: your work with the patient.
  • Delta leverages AI and computational linguistics to extract and analyse powerful scientific metrics from patients' answers.
  • Delta gives you comprehensive insight by visualising the extracted metrics. Combined with population cut-off values, this visualisation helps to enrich your professional impression
  • Delta compiles your test analysis, visualisations and your interpretation/diagnosis into a digital report formatted to your clinic's guidelines.

Jan Alexandersson continues: "We are hoping this prototype demo will help us find our potential first customers, collect feedback about our value proposition. We are also working on CE certification of our product and looking to extending our portfolio towards the German market by the end of 2018. For 2017, our focus is on the French market."

The mission of ki elements is to provide health professionals with AI-empowered tools as key elements to excel in their profession.

ELEMENT has implemented a first alpha version of the product targeting dementia diagnosis support for clinicians based on speech analysis.

Dementia is a cognitive disorder, mainly caused by neurodegenerative diseases, such as Alzheimer's disease but also strokes, which leads to a loss of autonomy and is associated with significant decrease in quality of life. In 2015 around the world, there were 9.9 million new cases of dementia: one every 3 seconds*. This number is expected to double every 20 years and reach 68% of the worldwide population in 2050 (mostly in low-medium income countries and due, in part, to fewer births and a growing elderly population).

Partners involved in the Innovation Activity are:

  • DFKI: Activity lead, coordination, mobile and app integration
  • ki elements (sub-grantee of DFKI GmbH): commercialisation of project results
  • Inria: Corpus collection, video analysis and clinical trials
  • University of Edinburgh: Trials and validation of current system for British English
  • Innovation Alzheimer (sub-grantee of INRIA): Clinical partner providing access to dementia patients for French corpus collection and tests. Clinical personnel will be involved.

    * Alzheimer's Disease International

    About EIT Digital
    EIT Digital seeks to generate significant innovations from top European research. As such, we focus our investments on a limited number of innovation areas known as Innovation Action Lines, that we have selected with respect to their European relevance and leadership potential. Each Innovation Action Line comprises a portfolio of activities including:

    • open innovation activities carried out by the EIT Digital Partners and
    • fast-growing technology startups that are ready to scale commercially.

    Our Innovation Activities deliver new products or services, create startups and spinoffs to commercialise outputs from projects and encourage the transfer of technologies for market entry.

  • Most Popular Now

    Philips Foundation 2024 Annual Report: E…

    Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

    New AI Transforms Radiology with Speed, …

    A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

    Scientists Argue for More FDA Oversight …

    An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

    New Research Finds Specific Learning Str…

    If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

    Giving Doctors an AI-Powered Head Start …

    Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

    AI Agents for Oncology

    Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

    Patients say "Yes..ish" to the…

    As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

    'AI Scientist' Suggests Combin…

    An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

    Brains vs. Bytes: Study Compares Diagnos…

    A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

    Start-ups in the Spotlight at MEDICA 202…

    17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...